Wei Wen Hou
Director/Board Member at MingMed Biotechnology Co., Ltd.
Profile
Wei Wen Hou is currently an Independent Non-Executive Director at MingMed Biotechnology Co., Ltd.
He completed his undergraduate degree at The Chinese University of Hong Kong in 1997 and earned an MBA from The Hong Kong University of Science & Technology in 2007.
Wei Wen Hou active positions
| Companies | Position | Start |
|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Director/Board Member | - |
Training of Wei Wen Hou
| The Chinese University of Hong Kong | Undergraduate Degree |
| The Hong Kong University of Science & Technology | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Stock Market
- Insiders
- Wei Wen Hou
